International Clinical Trial: Artificial Intelligence-Driven Medipixel Fractional Flow Reserve Versus Invasive Fractional Flow Reserve-Guided PCI Trial (AIM-FFR Trial)

Geneva, Feb. 13 -- International Clinical Trials Registry received information related to the study (NCT07329699) titled 'Artificial Intelligence-Driven Medipixel Fractional Flow Reserve Versus Invasive Fractional Flow Reserve-Guided PCI Trial (AIM-FFR Trial)' on Dec. 23, 2025.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Double (Participant, Outcomes Assessor).

Primary Sponsor: Samsung Medical Center

Condition: Coronary Artery Disease Chronic Coronary Syndrome Acute Coronary Syndrome

Intervention: Diagnostic Test: MPFFR or Invasive FFR

Recruitment Status: Not recruiting

Phase: N/A

Date of First Enrollment: March 1, 2026

Target...